Cargando…
Adjuvant therapy for endometrial cancer
Endometrial cancer is a common gynecologic malignancy typically diagnosed at early stage and cured with surgery alone. Adjuvant therapy is tailored according to the risk of recurrence, estimated based on the International Federation of Gynecology and Obstetrics (FIGO) stage and other histological fa...
Autores principales: | DeLeon, Maria C., Ammakkanavar, Natraj R., Matei, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996264/ https://www.ncbi.nlm.nih.gov/pubmed/24761218 http://dx.doi.org/10.3802/jgo.2014.25.2.136 |
Ejemplares similares
-
Controversies in the Adjuvant Therapy of Endometrial Cancer
por: Hsiao, Sheng-Mou, et al.
Publicado: (2011) -
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives
por: Giustozzi, Alessandra, et al.
Publicado: (2021) -
Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?
por: Zagouri, Flora, et al.
Publicado: (2010) -
Stage IIIC endometrial cancer review: Current controversies in adjuvant therapy
por: Buras, Andrea L., et al.
Publicado: (2021) -
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
por: van den Heerik, Anne Sophie V M, et al.
Publicado: (2021)